Envoy Medical Stock
Envoy Medical, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- Brent T. Lucas
- Employees
- 43
- Market cap
- $52 M
- IPO
- 29/04/2021
Envoy Medical, Inc. is a healthcare company dedicated to developing innovative medical technologies that address the full spectrum of hearing loss. Its diverse product portfolio includes conventional hearing aids, Esteem middle ear implants, bone conduction devices, and Acclaim cochlear implants. Established in 1995,…
Envoy Medical stock: price history
1D
+3.6%
1W
+1.6%
1M
-5.9%
6M
-5.7%
YTD
+1.0%
1Y
-21.4%
2Y
-75.4%
5Y
-93.1%
10Y
–
Next earnings date
Next earnings date
09/11/2026 (in 23 days)
Volatility around earnings
~46% weaker price swings than usual
Ask the agents about Envoy Medical
Analyst assessment of Envoy Medical
PRICE TARGET LOW
US$2.00
CONSENSUS
US$2.00
MEDIAN
US$2.00
PRICE TARGET HIGH
US$2.00
0
STRONG BUY
3
BUY
0
HOLD
0
SELL
0
STRONG SELL
3
TOTAL · Buy
As of: 21/08/2026
Envoy Medical stock metrics
P/E
-0.99
P/B
21.04
EV/EBITDA
-1.5
RETURN ON EQUITY
-181.1%
NET MARGIN
-11,729.4%
DEBT/EQUITY
0.25
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
56.0%
FLOAT SHARES
43,215,850
AVG. DAILY VOLUME (30D)
63,666
Insider transactions (SEC)
Lucas Brent T.
Institutional holders
Comparable stocks
Frequently asked questions about Envoy Medical stock
What does Envoy Medical do?
Envoy Medical, Inc. is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Brent T. Lucas, the company employs around 43 people.
The IPO was on 29/04/2021; the stock trades on NASDAQ under the ticker COCH.
What do analysts say about Envoy Medical stock?
3 analysts rate the stock, the consensus is Buy (as of 21/08/2026).
The average price target is US$2.00, ranging from US$2.00 to US$2.00, with a median of US$2.00.
This is an external assessment, not a statement by Market Jury.
When does Envoy Medical report next?
The next earnings date is 09/11/2026.
Around past earnings, price swings were roughly -46% stronger than usual.
Does Envoy Medical pay a dividend?
No, Envoy Medical currently does not pay a dividend.
Which stocks are comparable to Envoy Medical?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
How can I get Envoy Medical stock analyzed?
Clicking "Analyze stock" lets five strategies assess Envoy Medical against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.